Bollinger Band Analysis Review of Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

67

Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) for the period of 9-Day stands at 54.04% while the stochastic %D for the same period stands at 33.41%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) signals “Buy” while other important signals like the 20-Day Moving Average Vs. Price signals “Buy”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Sell” for Valeant Pharmaceuticals International, Inc. (NYSE:VRX) while 20-100 Day MACD Oscillator indicates “Sell”.

Bollinger band is a volatility indictor of a certain security, currently Valeant Pharmaceuticals International, Inc. (NYSE:VRX)’s 20-Day Bollinger Band indicates “Hold”.

Previous Day Activity Analysis

On the last trading day, Valeant Pharmaceuticals International, Inc. (NYSE:VRX) opened the session at $13.83 and after going up 4.26% closed at $14.19. The stock gained 0.36 points in the last trade.

Valeant Pharmaceuticals International, Inc. (NYSE:VRX)’s stock fluctuated in the range of $13.81 and $14.44 during the previous active session. Valeant Pharmaceuticals International, Inc. (NYSE:VRX) traded with the volume of 12.71 Million with average volume of 17.33 Million. The stock has LOW volatility on the last trading session.

Currently the Beta for the company remains at -0.38 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.6 and 48.45 respectively.

Currently the Insider Ownership of the shares of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) is at 2.3% and the shares outstanding are 350.1 Million.

Important Ratio Analysis

Some important ratios to consider here for Valeant Pharmaceuticals International, Inc. (NYSE:VRX) are discussed below:

Dividend yield of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) stands at 0% whereas Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 4.05.

The PEG ratio (Price to Earning to Growth) emits the value of 0. The Price to Sale P/S and Price to Book P/B shows the value of 0.54 and 1.26 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 4.09 and 2.28 correspondingly.

The Quick Ratio of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) stands at 1.1 while the Current Ratio depicts the value of 1.3.

Return on Assets ROA of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) is at -2.6% whereas, Return on Equity ROE and Return of Investment ROI of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) stand at -30.2% and -1.6% respectively.

The payout ratio of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) stands at 0%.

Stock Performance Analysis

The stock performance of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) on the basis of 5 day trade show the jump of 6.45% whereas, the monthly performance of the stock shows increase of 2.75%.

The quarterly performance of the stock remained in green zone with the value of 12.17% while six month performance of the shares of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) remained bullish with the count of 17.18%.

The yearly and YTD performance of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) remained down at -49.43% and -2.27% respectively.